Assetmark Inc. Has $29.29 Million Stock Position in Intuitive Surgical, Inc. $ISRG

by · The Cerbat Gem

Assetmark Inc. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 7.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 53,907 shares of the medical equipment provider’s stock after buying an additional 3,625 shares during the quarter. Assetmark Inc.’s holdings in Intuitive Surgical were worth $29,294,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. HBK Sorce Advisory LLC raised its position in Intuitive Surgical by 2.7% in the second quarter. HBK Sorce Advisory LLC now owns 3,854 shares of the medical equipment provider’s stock valued at $2,094,000 after purchasing an additional 101 shares during the last quarter. Premier Path Wealth Partners LLC grew its holdings in shares of Intuitive Surgical by 4.2% during the second quarter. Premier Path Wealth Partners LLC now owns 2,944 shares of the medical equipment provider’s stock worth $1,600,000 after purchasing an additional 120 shares during the last quarter. Hantz Financial Services Inc. increased its stake in shares of Intuitive Surgical by 4.4% in the second quarter. Hantz Financial Services Inc. now owns 15,592 shares of the medical equipment provider’s stock valued at $8,473,000 after buying an additional 652 shares during the period. Arkadios Wealth Advisors increased its stake in shares of Intuitive Surgical by 8.2% in the second quarter. Arkadios Wealth Advisors now owns 17,477 shares of the medical equipment provider’s stock valued at $9,497,000 after buying an additional 1,323 shares during the period. Finally, Barnes Dennig Private Wealth Management LLC raised its holdings in Intuitive Surgical by 682.9% in the 2nd quarter. Barnes Dennig Private Wealth Management LLC now owns 274 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 239 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $530.02 on Friday. The stock’s 50-day moving average is $463.16 and its 200 day moving average is $498.23. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market cap of $190.00 billion, a price-to-earnings ratio of 70.11, a PEG ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.84 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research reports. BTIG Research boosted their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Finally, Daiwa Capital Markets upped their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $608.92.

View Our Latest Report on ISRG

Insider Buying and Selling

In related news, Director Craig H. Barratt sold 2,193 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total transaction of $1,201,785.93. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 96,011 shares of company stock worth $50,309,042 over the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles